CN104447597A - 一种地克珠利的制备方法 - Google Patents
一种地克珠利的制备方法 Download PDFInfo
- Publication number
- CN104447597A CN104447597A CN201410616140.1A CN201410616140A CN104447597A CN 104447597 A CN104447597 A CN 104447597A CN 201410616140 A CN201410616140 A CN 201410616140A CN 104447597 A CN104447597 A CN 104447597A
- Authority
- CN
- China
- Prior art keywords
- preparation
- reaction
- solution
- chloro
- diclazuril
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 30
- ZSZFUDFOPOMEET-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-[2,6-dichloro-4-(3,5-dioxo-1,2,4-triazin-2-yl)phenyl]acetonitrile Chemical compound C1=CC(Cl)=CC=C1C(C#N)C1=C(Cl)C=C(N2C(NC(=O)C=N2)=O)C=C1Cl ZSZFUDFOPOMEET-UHFFFAOYSA-N 0.000 title claims abstract description 28
- 229960000248 diclazuril Drugs 0.000 title claims abstract description 28
- 238000006243 chemical reaction Methods 0.000 claims abstract description 60
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 claims abstract description 20
- HHLCSFGOTLUREE-UHFFFAOYSA-N 1,2,3-trichloro-5-nitrobenzene Chemical compound [O-][N+](=O)C1=CC(Cl)=C(Cl)C(Cl)=C1 HHLCSFGOTLUREE-UHFFFAOYSA-N 0.000 claims abstract description 11
- BIXZHMJUSMUDOQ-UHFFFAOYSA-N dichloran Chemical compound NC1=C(Cl)C=C([N+]([O-])=O)C=C1Cl BIXZHMJUSMUDOQ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000010288 sodium nitrite Nutrition 0.000 claims abstract description 10
- 238000006193 diazotization reaction Methods 0.000 claims abstract description 9
- 239000000243 solution Substances 0.000 claims description 32
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 31
- 238000003756 stirring Methods 0.000 claims description 29
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 24
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 23
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 20
- 239000007787 solid Substances 0.000 claims description 18
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 16
- 229960000583 acetic acid Drugs 0.000 claims description 15
- 239000012362 glacial acetic acid Substances 0.000 claims description 14
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 claims description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 12
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 12
- 238000000967 suction filtration Methods 0.000 claims description 11
- ZVCDLGYNFYZZOK-UHFFFAOYSA-M sodium cyanate Chemical compound [Na]OC#N ZVCDLGYNFYZZOK-UHFFFAOYSA-M 0.000 claims description 10
- 238000010792 warming Methods 0.000 claims description 10
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 9
- 239000000460 chlorine Substances 0.000 claims description 5
- 229910052801 chlorine Inorganic materials 0.000 claims description 5
- SUSQOBVLVYHIEX-UHFFFAOYSA-N phenylacetonitrile Chemical compound N#CCC1=CC=CC=C1 SUSQOBVLVYHIEX-UHFFFAOYSA-N 0.000 claims description 5
- QQVHQMAFAHWOOJ-UHFFFAOYSA-N C(C1=CC=CC=C1)#N.[Cl] Chemical compound C(C1=CC=CC=C1)#N.[Cl] QQVHQMAFAHWOOJ-UHFFFAOYSA-N 0.000 claims description 4
- 229910021626 Tin(II) chloride Inorganic materials 0.000 claims description 4
- 239000012954 diazonium Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 235000011150 stannous chloride Nutrition 0.000 claims description 4
- AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 claims description 4
- 229910021591 Copper(I) chloride Inorganic materials 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 3
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 claims description 3
- 229940045803 cuprous chloride Drugs 0.000 claims description 3
- 150000001989 diazonium salts Chemical class 0.000 claims description 3
- -1 intermediate 2 Chemical compound 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 claims description 3
- 238000000034 method Methods 0.000 abstract description 12
- 238000004440 column chromatography Methods 0.000 abstract description 7
- 239000002994 raw material Substances 0.000 abstract description 6
- 230000015572 biosynthetic process Effects 0.000 abstract description 5
- 238000007363 ring formation reaction Methods 0.000 abstract description 5
- 238000003786 synthesis reaction Methods 0.000 abstract description 5
- 238000006722 reduction reaction Methods 0.000 abstract description 3
- 238000009776 industrial production Methods 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 description 35
- 239000000047 product Substances 0.000 description 10
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 238000002425 crystallisation Methods 0.000 description 5
- 230000008025 crystallization Effects 0.000 description 5
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 4
- 230000001165 anti-coccidial effect Effects 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000013019 agitation Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- MLIREBYILWEBDM-UHFFFAOYSA-N cyanoacetic acid Chemical compound OC(=O)CC#N MLIREBYILWEBDM-UHFFFAOYSA-N 0.000 description 2
- 238000006114 decarboxylation reaction Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 238000006049 ring expansion reaction Methods 0.000 description 2
- 239000000273 veterinary drug Substances 0.000 description 2
- 241000224483 Coccidia Species 0.000 description 1
- 208000003495 Coccidiosis Diseases 0.000 description 1
- 241000223924 Eimeria Species 0.000 description 1
- 206010023076 Isosporiasis Diseases 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- DGJMPUGMZIKDRO-UHFFFAOYSA-N cyanoacetamide Chemical compound NC(=O)CC#N DGJMPUGMZIKDRO-UHFFFAOYSA-N 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-O diazynium Chemical compound [NH+]#N IJGRMHOSHXDMSA-UHFFFAOYSA-O 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000000192 social effect Effects 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410616140.1A CN104447597B (zh) | 2014-10-26 | 2014-10-26 | 一种地克珠利的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410616140.1A CN104447597B (zh) | 2014-10-26 | 2014-10-26 | 一种地克珠利的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104447597A true CN104447597A (zh) | 2015-03-25 |
CN104447597B CN104447597B (zh) | 2018-07-31 |
Family
ID=52894424
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410616140.1A Active CN104447597B (zh) | 2014-10-26 | 2014-10-26 | 一种地克珠利的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104447597B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107746390A (zh) * | 2017-11-21 | 2018-03-02 | 连云港市亚晖医药化工有限公司 | 抗球虫药地克珠利的制备方法 |
CN111517991A (zh) * | 2020-04-24 | 2020-08-11 | 常州齐晖药业有限公司 | 一种地克珠利杂质a的制备方法 |
CN111574411A (zh) * | 2020-04-24 | 2020-08-25 | 常州齐晖药业有限公司 | 一种地克珠利杂质b的制备方法 |
CN113248454A (zh) * | 2021-07-06 | 2021-08-13 | 山东国邦药业有限公司 | 一种制备2-[苯基]-1,2,4-三嗪-3,5(2h,4h)-二酮类化合物的方法 |
CN113999139A (zh) * | 2021-12-03 | 2022-02-01 | 杭州臻峰科技有限公司 | 制备2,6-二氯-α-(4-氯代苯基) -4-硝基苯乙腈的方法 |
CN117510426A (zh) * | 2024-01-04 | 2024-02-06 | 山东国邦药业有限公司 | 一种抗球虫类兽药三嗪环的合成方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0163177A2 (en) * | 1984-05-22 | 1985-12-04 | International Business Machines Corporation | Window borderline generating circuit for CRT display |
US4631278A (en) * | 1984-08-01 | 1986-12-23 | Janssen Pharmaceutica N.V. | Anti-protozoal α-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitrile derivatives, pharmaceutical compositions, and method of use therefor |
EP0457015A2 (de) * | 1990-05-17 | 1991-11-21 | Bayer Ag | Verwendung von substituierten 1,2,4-Triazindionen zur Bekämpfung von parasitären Protozoen |
US5830863A (en) * | 1988-06-20 | 1998-11-03 | Merrell Pharmaceuticals Inc. | Neurokinin A antagonists |
CN1062265C (zh) * | 1995-04-14 | 2001-02-21 | 武田药品工业株式会社 | 三嗪衍生物的制备方法 |
CN1158248C (zh) * | 2001-01-12 | 2004-07-21 | 广东海康兽药有限公司 | 禽畜抗球虫病药物地克珠利的生产工艺 |
CN101265238A (zh) * | 2007-12-12 | 2008-09-17 | 重庆天极旅业有限公司 | 一种三嗪环衍生物的合成方法 |
CN104098521A (zh) * | 2014-07-26 | 2014-10-15 | 威海出入境检验检疫局检验检疫技术中心 | 地克珠利及同位素内标d4-地克珠利的制备方法 |
-
2014
- 2014-10-26 CN CN201410616140.1A patent/CN104447597B/zh active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0163177A2 (en) * | 1984-05-22 | 1985-12-04 | International Business Machines Corporation | Window borderline generating circuit for CRT display |
US4631278A (en) * | 1984-08-01 | 1986-12-23 | Janssen Pharmaceutica N.V. | Anti-protozoal α-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitrile derivatives, pharmaceutical compositions, and method of use therefor |
US5830863A (en) * | 1988-06-20 | 1998-11-03 | Merrell Pharmaceuticals Inc. | Neurokinin A antagonists |
EP0457015A2 (de) * | 1990-05-17 | 1991-11-21 | Bayer Ag | Verwendung von substituierten 1,2,4-Triazindionen zur Bekämpfung von parasitären Protozoen |
CN1062265C (zh) * | 1995-04-14 | 2001-02-21 | 武田药品工业株式会社 | 三嗪衍生物的制备方法 |
CN1158248C (zh) * | 2001-01-12 | 2004-07-21 | 广东海康兽药有限公司 | 禽畜抗球虫病药物地克珠利的生产工艺 |
CN101265238A (zh) * | 2007-12-12 | 2008-09-17 | 重庆天极旅业有限公司 | 一种三嗪环衍生物的合成方法 |
CN104098521A (zh) * | 2014-07-26 | 2014-10-15 | 威海出入境检验检疫局检验检疫技术中心 | 地克珠利及同位素内标d4-地克珠利的制备方法 |
Non-Patent Citations (3)
Title |
---|
RICHARD E. ARMER等: "8-AMINOQUINOLINES AS ANTICOCCIDIALS-PART III", 《B IOORGANIC & MEDICINAL CHEMISTRY LETTERS》 * |
何林华等: "抗球虫地克珠利的合成", 《中国医药工业杂志》 * |
曹炜等: "地克珠利的合成研究", 《精细化工中间体》 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107746390A (zh) * | 2017-11-21 | 2018-03-02 | 连云港市亚晖医药化工有限公司 | 抗球虫药地克珠利的制备方法 |
CN107746390B (zh) * | 2017-11-21 | 2021-03-16 | 连云港市亚晖医药化工有限公司 | 抗球虫药地克珠利的制备方法 |
CN111517991A (zh) * | 2020-04-24 | 2020-08-11 | 常州齐晖药业有限公司 | 一种地克珠利杂质a的制备方法 |
CN111574411A (zh) * | 2020-04-24 | 2020-08-25 | 常州齐晖药业有限公司 | 一种地克珠利杂质b的制备方法 |
CN113248454A (zh) * | 2021-07-06 | 2021-08-13 | 山东国邦药业有限公司 | 一种制备2-[苯基]-1,2,4-三嗪-3,5(2h,4h)-二酮类化合物的方法 |
CN113248454B (zh) * | 2021-07-06 | 2021-09-24 | 山东国邦药业有限公司 | 一种制备2-[苯基]-1,2,4-三嗪-3,5(2h,4h)-二酮类化合物的方法 |
CN113999139A (zh) * | 2021-12-03 | 2022-02-01 | 杭州臻峰科技有限公司 | 制备2,6-二氯-α-(4-氯代苯基) -4-硝基苯乙腈的方法 |
CN117510426A (zh) * | 2024-01-04 | 2024-02-06 | 山东国邦药业有限公司 | 一种抗球虫类兽药三嗪环的合成方法 |
CN117510426B (zh) * | 2024-01-04 | 2024-04-19 | 山东国邦药业有限公司 | 一种抗球虫类兽药三嗪环的合成方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104447597B (zh) | 2018-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104447597A (zh) | 一种地克珠利的制备方法 | |
CN102060769B (zh) | 一种托伐普坦的制备方法 | |
CN105523981A (zh) | 一种二苯碲醚衍生物及其制备方法 | |
CN102964313A (zh) | 一种非布索坦的合成方法 | |
CN103193608B (zh) | 一种以藜芦醚为原料制备邻藜芦醛的方法 | |
CN109942527A (zh) | 一种3-溴二苯并呋喃的合成方法 | |
CN103420842B (zh) | 一种2,3,4-三氟硝基苯的制备方法 | |
CN105218445B (zh) | 一种酪氨酸激酶抑制剂Foretinib的制备方法 | |
CN106397235A (zh) | 一种溴芬酸钠的制备方法 | |
CN101531654A (zh) | 一种卢帕他定的制备方法 | |
CN103396318B (zh) | 一种2,4-二硝基苯甲醚的合成工艺 | |
CN105669357B (zh) | 一种1,4-二碘苯的绿色制备工艺 | |
CN104628577A (zh) | 盐酸溴己新的合成方法 | |
CN105523995A (zh) | 一种咯萘啶中间体2-甲氧基-5-氨基吡啶的制备方法 | |
CN102060717A (zh) | 3-氨基-4-溴苯酚的合成方法 | |
CN110981832A (zh) | 一种盐酸罗沙替丁醋酸酯的制备方法 | |
CN102924362B (zh) | 一种六氢-2-环戊并吡咯基胺盐酸盐的制备方法 | |
CN104447355A (zh) | 一种制备盐酸溴己新的新方法 | |
CN107011288B (zh) | 一种阿立哌唑中间体1-(2,3-二氯苯基)哌嗪盐酸盐的制备方法 | |
CN106905234B (zh) | 一种合成来那替尼中间体3-氰基-4-氯-6-氨基-7-乙氧基喹啉的方法 | |
CN102675148B (zh) | 对羟基苯乙腈的制备方法 | |
CN102249962B (zh) | 一种1,1-二硫-1-烯烃的制备方法 | |
CN106478422A (zh) | 一种对硝基苯乙酸的制备方法 | |
CN1281576C (zh) | 一种红色基gl的制备方法 | |
CN104003887B (zh) | 一种盐酸溴己新的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180112 Address after: Tianrun road Wendeng Economic Development Zone in Weihai City, Shandong Province, No. 268 264205 Applicant after: WEIHAI DISU PHARMACEUTICAL Co.,Ltd. Applicant after: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Address before: 264205 Shandong province Weihai Jing District Qilu Avenue - No. 55-1 scientific research building 303 Applicant before: WEIHAI PURUISEN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191106 Address after: 264205 Guangzhou East Road South and an East Road East, Wendeng economic and Technological Development Zone, Weihai City, Shandong Province Co-patentee after: WEIHAI DISU PHARMACEUTICAL Co.,Ltd. Patentee after: Dijia Pharmaceutical Group Co.,Ltd. Co-patentee after: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Address before: Tianrun road Wendeng Economic Development Zone in Weihai City, Shandong Province, No. 268 264205 Co-patentee before: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Patentee before: WEIHAI DISU PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210610 Address after: No.1 Qingdao South Road, Weihai Economic and Technological Development Zone, Shandong Province Patentee after: Dijia Pharmaceutical Group Co.,Ltd. Address before: 264205 Wendeng economic and Technological Development Zone, Weihai City, Shandong Province Patentee before: Dijia Pharmaceutical Group Co.,Ltd. Patentee before: WEIHAI DISU PHARMACEUTICAL Co.,Ltd. Patentee before: DISHA PHARMACEUTICAL GROUP Co.,Ltd. |
|
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 264205 268 Tianrun Road, Wendeng economic and Technological Development Zone, Weihai, Shandong Patentee after: Dijia Pharmaceutical Group Co.,Ltd. Address before: No.1 Qingdao South Road, Weihai Economic and Technological Development Zone, Shandong Province Patentee before: Dijia Pharmaceutical Group Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: No. 268, Tianrun Road, Wendeng Economic and Technological Development Zone, Weihai City, Shandong Province, 264200 Patentee after: Dijia Pharmaceutical Group Co.,Ltd. Address before: 264205 268 Tianrun Road, Wendeng economic and Technological Development Zone, Weihai, Shandong Patentee before: Dijia Pharmaceutical Group Co.,Ltd. |